Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.
Onder Onguru, Mary B Casey, Sabine Kajita, Nobuki Nakamura, Ricardo V Lloyd
Index: Endocr. Pathol. 16(4) , 253-77, (2005)
Full Text: HTML
Abstract
Prostaglandins (PG) are members of a large group of hormonally active fatty acids derived from free fatty acids. They are formed from arachidonic acid-the major PG precursor. Cyclooxygenase (COX)-1 and -2 are the rate-limiting steps in PG synthesis. COX-2 is overexpressed in many human non-endocrine and endocrine tumors including colon, breast, prostate, brain, thyroid, and pituitary. COX-2 has an important role in angiogenesis and tumor growth. Thromboxane synthase (TS) catalyzes the synthesis of thromboxane A2 (TXA2), which is derived from arachidonic acid and prostaglandin H2 and is a vasoconstrictor and inducer of platelet aggregation. TXA2 stimulates tumor growth and spread of some tumors and TS appears to have a critical role in tumorigenesis in some organ systems. In this review, we examine the role of COX-2 and TS in various non-endocrine tumors, especially colon, breast, prostate, and brain as well as in endocrine tumors. The accumulating evidence points to an increasingly important role of COX-2 and TS in tumor progression and metastasis.
Related Compounds
Related Articles:
What we know about primary dysmenorrhea today: a critical review.
2015-01-01
[Hum. Reprod. Update 21 , 762-78, (2015)]
1993-05-25
[Biochem. Pharmacol. 45(10) , 2071-8, (1993)]
1988-12-25
[J. Biol. Chem. 263(36) , 19384-91, (1988)]
2002-01-01
[Thromb. Haemost. 87(1) , 114-21, (2002)]
Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
2005-01-01
[Antioxid. Redox Signal. 7(1-2) , 185-201, (2005)]